(Q42201957)

18 October 2017

title

Controlled clinical assessment of astemizole in the treatment of chronic idiopathic urticaria and angioedema (English)

1 reference

18 October 2017

1 reference

1 reference

Kailasam V

1

1 reference

18 October 2017

Mathews KP

series ordinal

2

1 reference

18 October 2017

language of work or name

English

0 references

publication date

1 April 1987

1 reference

Journal of the American Academy of Dermatology

18 October 2017

published in

1 reference

18 October 2017

volume

16

1 reference

18 October 2017

issue

4

1 reference

18 October 2017

page(s)

797-804

1 reference

Astemizole. A review of its pharmacodynamic properties and therapeutic efficacy

18 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970104-2

7 January 2021

Efficacy and safety of astemizole, a long-acting and nonsedating H1 antagonist for the treatment of chronic idiopathic urticaria

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970104-2

7 January 2021

Performance studies with the H1-histamine receptor antagonists, astemizole and terfenadine

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970104-2

7 January 2021

Treatment of chronic idiopathic urticaria with terfenadine

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970104-2

7 January 2021

Comparative trial of two non-sedative H1 antihistamines, terfenadine and astemizole, for hay fever

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970104-2

7 January 2021

Urticaria and angioedema

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970104-2

7 January 2021

Delayed pressure urticaria

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970104-2

7 January 2021

10.1016/S0190-9622(87)70104-2

Identifiers

DOI

1 reference

18 October 2017

1 reference